Video, Steep Hill PZOO Partner Sep 16, 2015
Episode 10: David Lampach, the co-founder and CEO of Steep Hill Labs
Steep Hill is the country’s leading cannabis science and technology firm. Since opening their first commercial cannabis lab in 2008, Steep Hill has grown immensely. They now have labs in CA, WA, CO, and NV with plans for expansion into NM and OR very soon. Brandon and David will dive into why testing cannabis is so important for consumers, medical v recreational cannabis differences, and the many new products coming out of their R&D lab including the QuantaCann and the GenKit.
Pazoo's testing lab subsidiaries and partners are in position to become the leading
cannabis testing and certification operation in the United States:
Top 4 reasons Pazoo is worth investing in
1) Steep Hill methodology and first right of refusal
They have been studying the plant and perfecting their testing methodology for 8+ years.
2) Strategic positioning
Pazoo has lab locations in the three most profitable states for testing (Nevada, Oregon, and Colorado- in that order). Testing will begin in all three by the 4th quarter (we could still have CO in the 3rd)
3) CannabisKing Distribution
Management has been proactive and created another revenue stream for the company with products expected to have substantial footholds in the sector (MJ Payments, AccuVape, and several others)
4) Transparency and Diligence of Management
David Cunic (CEO) and the pzoo team have been straightforward and upfront about their progress. There have been setbacks and delays that were out of their control, but they have used that time positively. They moved into the sector late last year and already have partnered with the best in class (Steep hill), have 3 testing labs, other revenue, and future expansion plans.
Competitive Advantage: PZOO's 2 primary competitors are Digipath (Nevada) and Cannlabs (Colorado).
1) Testing Methodology- The closest competitors have only been testing for 2-3 years and this has been evident in a various instances including the independent Nevada tests scoring Steep hill at 241/250 and the closest competitor around 190. CannLabs also recently could not perform tests promised to their customers due to lack of expertise.
Each of those competitors only have 1 lab, in 1 state, and have made 0 announcements about expansion. Pzoo will have 3 this year and has announced plans to open 2 more labs in 2016.
3) Effectiveness and Efficiency
Digipath had their first PR saying they were testing MJ in early June and claimed to be supplying the first open dispensary in Vegas. The reality is that they are only testing a couple samples a week and running their lab at a loss, bleeding cash. For all of you who want to be able to say we have "testing revenue coming in" this is our current alternative. Until substantial grow operations have produced crops, there is no point to having the facility open and running at a loss.
Until Pzoo has steady revenue and is running at a profit (projected by end of Q4, but likely beginning of Q1 in 2016), having access to operating capital without taking out toxic debt will be imperative. The PR discussing Luchesi bringing them into contact with private financing is encouraging. Hopefully we will find out whether they were successful soon.
2) Federal Regulation
Like any company in the MJ sector, Federal regulation could severely hamper or halt PZOOs progress. There are no presidential candidates that have a legitimate chance of winning who have spoken out against the MJ industry at this point.
Pazoo, Inc. (OTCPK: PZOO)
Pazoo, Inc., is a company focused on health, wellness and safety. Our focus is to provide best in class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly owned subsidiary, Harris Lee, and our partnership with MA & Associates, Pazoo provides industry leading laboratory testing of cannabis. Pazoo’s license agreement with Steep Hill Labs Inc. allows us to use their best in market testing protocols on a right of first refusal basis as we expand throughout the USA. Pazoo is licensed to test cannabis in Nevada, Colorado, and Oregon, with a focus on expansion into other states.
Our newest subsidiary is 100% wholly owned CannabisKing Distribution, We’re making it easier for growing facilities, infusion companies and dispensaries to reap healthier sales with equipment, supplies and consumer products from, CannabisKing Distribution. Count on CannabisKing as your one-stop nationwide source for the highest quality goods, sales assistance and customer support.
stocktrademan PZOO DD Links
Nevada Testing Puts Pazoo #1
Pazoo Launches Pazoo Investor Facebook Page, Posts Updates on Company and Las Vegas Facility Buildout Done by Ryan Taylor
Pazoo, Inc., As Promised, Pays Off LG Capital LLC Note, Receives Traditional Investment Oct. 1, 2015
Pazoo expects be able to pay off other Notes within the next few weeks.
Pazoo, Inc. Receives $200,000 Loan To Make Las Vegas Testing Lab Fully Operational In November Of This Year Sept. 24, 2015
Pazoo has received a $200,000 Loan to be paid back from the revenue and earnings of the Las Vegas Facility. There can be no debt to equity conversion as this is a more conventional form of financing.
Pazoo Wholly-Owned Subsidiary, CannabisKing Distribution, Adds A Revolutionary One-Of-A-Kind Patented Water Conservation Product Sept. 9, 2015
Pazoo, Inc. To Present On Cannabis InvestorWebcast Sept. 3, 2015
Pazoo, Inc. Subsidiary CannabisKing Distribution Adds Over 10 New Accounts; Company Receives Steady Reorders and Additional Commitments for AccuVape Sept 2, 2015
Luchesi & Brand has already delivered business for CannabisKing for the AccuVape product line, has potential accounts for MJ Payment lined up, as well as connected some growers with our current testing labs
Pazoo Wholly-Owned Subsidiary Harris Lee Announces Agreement in Principal with Harris Lee Colorado, LLC to Operate New Lab in Colorado Cannabis Testing Market- May 20, 2015 http://www.otcmarkets.com/stock/PZOO/news/Pazoo-Wholly-Owned-Subsidiary-Harris-Lee-Announces-Agreement-in-Principal-with-Harris-Lee-Colorado--LLC-to-Operate-New-Lab-in-Colorado-Cannabis-Testing-Market?id=105129&b=y MoneyTV with Donald Baillargeon - May 15, 2015 http://www.otcmarkets.com/stock/PZOO/news/MoneyTV-with-Donald-Baillargeon--5-15?id=104668&b=y Pazoo Provides Business Development Update - May 14, 2015
Transcript PZOO Q2 2015 Earnings Conference Call August 26, 2015 12:00 PM ET
Excerpt from CC
David Cunic - CEO
This is a great question, I am happy a shareholder emailed this to us. We believe the valuation of the company is highly undervalued, when you compares us to our main competitors and what their stock prices are currently at. One needs to remember we just went to the Marijuana sector less than a year ago and there is a very high barrier cost to enter the Marijuana sector and even higher level cost when entering the lab sector within the Marijuana industry. Now if you were to look at this year alone, let’s review some of the major accomplishment Pazoo has achieved in last seven months and I’m going to go through those right now.
http://www.otcmarkets.com/stock/PZOO/news/Pazoo-Provides-Business-Development-Update?id=104568&b=y Pazoo, Inc 10K - May 14, 2015
Pazoo's Partner, MA & Associates, LLC, Joins Inaugural Nevada Cannabis Association - April 21, 2015
Pazoo Partner, MA and Associates, LLC Hires Industry Sales Vet Michael A. Tulimero to Head Up MA's Newly Created Marketing and Sales Division - April 13, 2015
Click for Read
Pazoo's Harris Lee to Take Over Operations at Colorado Marijuana Testing Facility - April 1, 2015
Click for Read
Pazoo Provides Business Development and Expansion Plan Update - March 31, 2015
Click for Read
Pazoo CEO Interview Money TV with Donald Baillargeon - March 20, 2015
Click to Read
March 19, 2015 Click to Read Pazoo Medical Marijuana Partner, MA & Associates, LLC, Receives a Two Year Exclusive Contract From One Grower for Up to 875,000 Square Feet of Grow - December 15, 2014 Click to Read
|CEO: ||David Cunic |
|Issue Type: ||Common Stock |
|Auditors: ||MaloneBailey, LLP |
DAVID CUNIC, PT CEO, PAZOO
|Market Value ||$889,236,686 ||a/o March 12, 2015 |
|Shares Outstanding ||728,390,950 ||a/o Auguest 19, 2015 |
|Float ||449,536,555 ||a/o April 22, 2015 |
|Authorized Shares ||980,000,000 ||a/o April 22, 2015 |